Keel Point LLC grew its position in shares of CVS Health Corp (NYSE:CVS) by 24.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,535 shares of the pharmacy operator’s stock after acquiring an additional 879 shares during the quarter. Keel Point LLC’s holdings in CVS Health were worth $357,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of CVS. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of CVS Health by 2.4% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,334,640 shares of the pharmacy operator’s stock worth $262,503,000 after buying an additional 76,995 shares during the last quarter. Cadinha & Co. LLC raised its stake in CVS Health by 59.9% in the 3rd quarter. Cadinha & Co. LLC now owns 8,812 shares of the pharmacy operator’s stock valued at $694,000 after acquiring an additional 3,300 shares during the period. Howe & Rusling Inc. raised its stake in CVS Health by 62,993.1% in the 3rd quarter. Howe & Rusling Inc. now owns 163,411 shares of the pharmacy operator’s stock valued at $12,864,000 after acquiring an additional 163,152 shares during the period. Advisor Partners LLC raised its stake in CVS Health by 8.8% in the 3rd quarter. Advisor Partners LLC now owns 30,404 shares of the pharmacy operator’s stock valued at $2,393,000 after acquiring an additional 2,469 shares during the period. Finally, Flippin Bruce & Porter Inc. raised its stake in CVS Health by 4.6% in the 3rd quarter. Flippin Bruce & Porter Inc. now owns 144,139 shares of the pharmacy operator’s stock valued at $11,347,000 after acquiring an additional 6,393 shares during the period. 83.03% of the stock is currently owned by hedge funds and other institutional investors.

Shares of CVS opened at $75.52 on Wednesday. CVS Health Corp has a twelve month low of $60.14 and a twelve month high of $83.88. The stock has a market cap of $80.03 billion, a PE ratio of 12.80, a P/E/G ratio of 1.05 and a beta of 0.98. The company has a current ratio of 2.44, a quick ratio of 1.94 and a debt-to-equity ratio of 1.66.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The firm had revenue of $47.27 billion for the quarter, compared to analysts’ expectations of $47.22 billion. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The company’s revenue was up 2.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.50 earnings per share. As a group, sell-side analysts predict that CVS Health Corp will post 7.02 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 1st. Investors of record on Wednesday, October 24th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.65%. The ex-dividend date of this dividend was Tuesday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 33.90%.

A number of equities research analysts recently issued reports on the company. Argus boosted their price objective on CVS Health to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 13th. Royal Bank of Canada set a $100.00 price objective on CVS Health and gave the company a “buy” rating in a research note on Wednesday, November 7th. Loop Capital set a $80.00 price objective on CVS Health and gave the company a “hold” rating in a research note on Friday, November 9th. Morgan Stanley set a $100.00 price objective on CVS Health and gave the company a “buy” rating in a research note on Wednesday, November 7th. Finally, ValuEngine upgraded CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, October 11th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the company’s stock. CVS Health currently has a consensus rating of “Buy” and a consensus price target of $90.04.

In related news, EVP Kevin Hourican sold 8,564 shares of the company’s stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $75.00, for a total value of $642,300.00. Following the transaction, the executive vice president now directly owns 12,135 shares in the company, valued at $910,125. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Eva C. Boratto sold 13,311 shares of the company’s stock in a transaction that occurred on Monday, September 17th. The stock was sold at an average price of $77.16, for a total transaction of $1,027,076.76. Following the completion of the transaction, the executive vice president now owns 55,162 shares in the company, valued at $4,256,299.92. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 57,638 shares of company stock worth $4,558,875. 0.53% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: “Keel Point LLC Has $357,000 Holdings in CVS Health Corp (CVS)” was first published by Daily Political and is the sole property of of Daily Political. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://www.dailypolitical.com/2018/11/21/keel-point-llc-has-357000-holdings-in-cvs-health-corp-cvs.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Story: Cost of Debt

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.